In 1992, Spinelli et al. (1) first described metallic stent placement within the colon for treatment of malignant large bowel obstruction. Since then, metallic stents have been increasingly used for safe nonsurgical palliation for unresectable malignant colorectal obstructions and as a bridge to surgery to allow stabilization of the patient’s condition (2,3,4,5,6,7,8,9,10,11,12,13,14,15,16). Because surgical decompression has been associated with high morbidity and mortality, minimally invasive stent placement is preferred to open surgery (2,11,12,13). Colorectal stent placement is performed via the transanal route under a fluoroscopic guidance alone or in combination with endoscopy. Placement under conscious sedation is generally well tolerated by patients. The procedure allows immediate large bowel decompression with rapid resolution of patients’ symptoms and restoration of normal intestinal transit (11,12).